Results 31 to 40 of about 4,083,225 (263)

Statin non-adherence: clinical consequences and proposed solutions [version 1; referees: 2 approved] [PDF]

open access: yesF1000Research, 2016
Large controlled clinical trials have demonstrated reductions with statin therapy in cardiovascular events in patients presenting with acute coronary syndromes and stable coronary heart disease and individuals at high risk of a cardiovascular event.
Robert S. Rosenson
doaj   +2 more sources

Effects of Statin Intensity on Clinical Outcome in Acute Myocardial Infarction Patients

open access: yesCirculation Journal, 2018
BACKGROUND There has been debate regarding the added benefit of high-intensity statins compared with low-moderate-intensity statins, especially in patients with acute myocardial infarction (AMI).Methods and Results:The Korea Acute Myocardial Infarction ...
Myung Ho Jeong   +2 more
exaly   +2 more sources

Temporal Trends of High‐Intensity Statin Therapy Among Veterans Treated With Percutaneous Coronary Intervention

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundThe 2013 American College of Cardiology/American Heart Association blood cholesterol guideline recommends high‐intensity statin therapy among certain groups of patients, but full implementation of the guideline has not yet been satisfactory. We
Aref A. Bin Abdulhak   +8 more
doaj   +2 more sources

Age differences on maintenance proportion of statin-intensity.

open access: yes, 2022
Age differences on maintenance proportion of statin-intensity.
Kiyuk Chang (3620258)   +18 more
core   +1 more source

High-intensity statin therapy yields better outcomes in acute coronary syndrome patients: a meta-analysis involving 26,497 patients

open access: yesLipids in Health and Disease, 2020
Background Whether high-intensity statin treatment provides more clinical benefits compared with standard statin regimens in acute coronary syndrome (ACS) patients remains controversial. This meta-analysis aimed to comparatively assess high-intensity and
Shiyong Yu   +3 more
doaj   +1 more source

Efficacy, safety and clinical outcome associated with statin use for primary prevention in Korean patients with low-density lipoprotein cholesterol level ≥ 190 mg/dL: A retrospective cohort study.

open access: yesPLoS ONE, 2023
BackgroundAlthough the current guideline recommends the use of high-intensity statin to reduce the low-density lipoprotein cholesterol (LDL-C) level by 50% in patients with baseline value of ≥ 190 mg/dL, direct application of this recommendation to Asian
Hack-Lyoung Kim   +5 more
doaj   +1 more source

Clinical outcome according to statin intensity.

open access: yes, 2023
BackgroundAlthough the current guideline recommends the use of high-intensity statin to reduce the low-density lipoprotein cholesterol (LDL-C) level by 50% in patients with baseline value of ≥ 190 mg/dL, direct application of this recommendation to Asian
Joo-Hee Zo (721373)   +5 more
core   +1 more source

Phenotype standardization for statin-induced myotoxicity. [PDF]

open access: yes, 2014
Statins are widely used lipid-lowering drugs that are effective in reducing cardiovascular disease risk. Although they are generally well tolerated, they can cause muscle toxicity, which can lead to severe rhabdomyolysis.
Fahy, J.   +41 more
core   +1 more source

Lipid Testing and Statin Dosing After Acute Myocardial Infarction

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
BackgroundThe 2013 American College of Cardiology/American Heart Association cholesterol guidelines recommend high‐intensity statins for patients after myocardial infarction (MI) rather than treating to a low‐density lipoprotein cholesterol goal, as the ...
William T. Wang   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy